BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/8/2025 7:11:44 AM | Browse: 4 | Download: 0
| Category |
Urology & Nephrology |
| Manuscript Type |
Minireviews |
| Article Title |
Sodium-glucose cotransporter-2 inhibitors beyond glycemic control: Their role in acute kidney injury recovery
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Muhammad Umar Ahsan, Sana Iftikhar, Umme E Ambreen, Fahad Nazir, Matia Fawad, Khadija Nasir and Ume Roman Leghari |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Muhammad Umar Ahsan, Researcher, Department of Medicine, D.G.Khan Medical College, Dera Ghazi Khan 32200, Punjab, Pakistan. umarahsan219@gmail.com |
| Key Words |
Sodium-glucose cotransporter-2 inhibitors; Acute kidney injury; Renal protection; Ischemia-reperfusion; Oxidative stress; Tubuloglomerular feedback |
| Core Tip |
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, traditionally used for glycemic control in type 2 diabetes, show emerging promise in acute kidney injury (AKI) recovery through mechanisms such as oxidative stress reduction, anti-inflammatory effects, improved mitochondrial function, and hemodynamic modulation. Although encouraging data from preclinical and observational studies exist, robust randomized controlled trials are lacking. This mini-review synthesizes current evidence, evaluates its quality, summarizes ongoing clinical trials, and highlights priority areas for future research to guide the safe and effective integration of SGLT2 inhibitors into AKI management. |
| Citation |
Ahsan MU, Iftikhar S, Ambreen UE, Nazir F, Fawad M, Nasir K, Leghari UR. Sodium-glucose cotransporter-2 inhibitors beyond glycemic control: Their role in acute kidney injury recovery. World J Nephrol 2025; In press |
 |
Received |
|
2025-07-23 01:55 |
 |
Peer-Review Started |
|
2025-07-23 01:56 |
 |
First Decision by Editorial Office Director |
|
2025-08-01 09:32 |
 |
Return for Revision |
|
2025-08-01 09:32 |
 |
Revised |
|
2025-08-15 20:58 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-12-08 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-08 07:11 |
 |
Articles in Press |
|
2025-12-08 07:11 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345